AxoSim, a New Orleans-based life science company focused on neurological disease, announced on Tuesday that it has appointed Stuart Gibb as its new vice president of Sales and Marketing.
In this role Gibb will be responsible for building and leading the sales organisation and strengthening the company's commercial presence.
Gibb has more than 20 years of global sales leadership experience. He has worked as VP of Sales and Marketing at Nortis Biosciences, VP of Global Sales at Araceli Biosciences, VP of Global Sales at Emulate, and held senior sales roles at Thermo Fisher Scientific and Becton Dickinson & Co.
Alif Saleh, AxoSim CEO, said: "We are excited to welcome Stuart as a key member of our team. He has an impressive track record in commercialising and scaling organ-on-a-chip platforms from zero to multi-million-dollar businesses."
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business
Insmed receives highest ranking in Science's 2024 Top Employers Survey
OncoZenge partners with Pharmanovia for exclusive BupiZenge commercialization in EMENA regions